These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3038169)

  • 41. Molecular biology of the angiotensinogen and kininogen genes.
    Kitamura N; Ohkubo H; Nakanishi S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S49-53. PubMed ID: 2485063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Formation of human immunoreactive LMW and HMW-kininogens during coagulation. Comparison with bradykinin activity].
    Adam A; Damas J; Calay G; Franchimont P
    C R Seances Soc Biol Fil; 1982; 176(1):73-81. PubMed ID: 6461398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purification and immunochemical properties of human low molecular weight kininogen.
    Sakamoto W; Nishikaze O
    J Biochem; 1979 Nov; 86(5):1549-57. PubMed ID: 118172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification and characterization of a Ca(2+)-activated thiol protease from Drosophila melanogaster.
    Pintér M; Stierandova A; Friedrich P
    Biochemistry; 1992 Sep; 31(35):8201-6. PubMed ID: 1525160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the autolyzed and unautolyzed forms of mu- and m-calpain from bovine skeletal muscle.
    Edmunds T; Nagainis PA; Sathe SK; Thompson VF; Goll DE
    Biochim Biophys Acta; 1991 Apr; 1077(2):197-208. PubMed ID: 2015293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High molecular weight kininogen as substrate for cathepsin B.
    Barros NM; Tersariol IL; Oliva ML; Araújo MS; Sampaio CA; Juliano L; Motta G
    Biol Chem; 2004 Jun; 385(6):551-5. PubMed ID: 15255189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.
    Proud D; Pierce JV; Pisano JJ
    J Lab Clin Med; 1980 Apr; 95(4):563-74. PubMed ID: 6153694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The calpain-calpastatin system and the calcium paradox in the isolated perfused pigeon heart.
    Gaitanaki C; Papazafiri P; Beis I
    Cell Physiol Biochem; 2003; 13(3):173-80. PubMed ID: 12876388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reconstitution of calpain I and calpain II from their subunits: interchangeability of the light subunits.
    Kikuchi T; Yumoto N; Sasaki T; Murachi T
    Arch Biochem Biophys; 1984 Nov; 234(2):639-45. PubMed ID: 6093703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Various properties and kinetics of interaction of high and low molecular weight human kininogens with human plasma kallikrein].
    Nartikova VF; Egorova TP; Rets EV; Paskhina TS
    Biokhimiia; 1986 Mar; 51(3):463-71. PubMed ID: 3634630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen.
    Kleniewski J; Donaldson VH
    J Lab Clin Med; 1987 Apr; 109(4):469-79. PubMed ID: 2950194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain.
    Díaz BG; Gross S; Assfalg-Machleidt I; Pfeiler D; Gollmitzer N; Gabrijelcic-Geiger D; Stubbs MT; Fritz H; Auerswald EA; Machleidt W
    Biol Chem; 2001 Jan; 382(1):97-107. PubMed ID: 11258679
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
    Mandle RJ; Colman RW; Kaplan AP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of calpain I and calpain II: a comparative study using terbium as a fluorescent probe for calcium-binding sites.
    Zimmerman UJ; Schlaepfer WW
    Arch Biochem Biophys; 1988 Nov; 266(2):462-9. PubMed ID: 2847653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets.
    Gustafson EJ; Lukasiewicz H; Wachtfogel YT; Norton KJ; Schmaier AH; Niewiarowski S; Colman RW
    J Cell Biol; 1989 Jul; 109(1):377-87. PubMed ID: 2526132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of brain calpains.
    Nilsson E; Karlsson JO
    J Neurochem; 1986 Oct; 47(4):1086-90. PubMed ID: 3018157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of calpain I and calpain II from carp muscle.
    Toyohara H; Makinodan Y
    Comp Biochem Physiol B; 1989; 92(3):577-81. PubMed ID: 2539943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.